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Objective: To describe the clinical, electrophysiological and imaging ﬁndings from
Parsonage–Turner syndrome and evaluate the results from conservative treatment.
Methods: Eight cases were studied between February 2010 and February 2012, with a min-
imum  follow-up of one year (mean of 14 months). All the patients answered a clinical
questionnaire and underwent functional evaluation using the Constant and Murley score.
After clinical suspicion was raised, an electromyography examination was performed to
conﬁrm the diagnosis.
Results: Eight patients (mean age of 29 years) were evaluated. The right side was affected in
70%  of the cases, and the dominant side in 80% of the cases. All the patients reported that
their shoulder pain had started suddenly, lasting from one to ﬁve days in six cases and up
to  15 days in two cases. In three cases, severe atrophy of the deltoid muscle was observed.
Hypotrophy of the supraspinatus and infraspinatus muscles was observed in three cases. A
winged scapula was observed in the two remaining cases. Electromyography demonstrated
involvement of the long thoracic nerve in these last two cases and conﬁrmed the involve-
ment of the axillary and suprascapular nerves in the remaining six cases. The mean score on
the  Constant and Murley scale was 96 at the end of the conservative treatment with non-
steroidal anti-inﬂammatory drugs and physiotherapy. Six of the eight patients presented
good recovery of muscle strength.
Conclusions: In the majority of the cases, the functional recovery was good, although muscle
strength was not completely restored in some of them.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved.
Síndrome  de  Parsonage–TurnerPalavras-chave:
Neurite do plexo braquial
r  e  s  u  m  o
Objetivo: Descrever os achados clínicos, eletroﬁsiológicos e de imagem na síndrome de
Parsonage–Turner e avaliar os resultados do tratamento conservador.
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Ombro
Eletromiograﬁa
Métodos: Foram estudados oito casos entre fevereiro de 2010 e fevereiro de 2012, com segui-
mento mínimo de um ano (média de 14 meses). Todos os pacientes foram submetidos ao
questionário clínico e avaliados funcionalmente com o escore de Constant e Murley. Após
a  suspeita clínica o exame de eletroneuromiograﬁa foi feito para conﬁrmac¸ão diagnóstica.
Resultados: Oito pacientes (média de 29 anos) foram avaliados. O lado direito foi acometido
em 70% dos casos e era o dominante em 80%. Todos os pacientes relataram um início súbito
de  dor no ombro, com durac¸ão de um a cinco dias em seis casos e de até 15 dias em dois casos.
Em três casos foi observada atroﬁa severa do músculo deltoide. Hipotroﬁa dos músculos
supraespinhal e infraespinhal foi observada em três casos. Escápula alada foi observada em
dois casos restantes. A eletromiograﬁa demonstrou envolvimento do nervo torácico longo
nesses dois últimos casos e conﬁrmou o envolvimento dos nervos axilar e supraescapu-
lar  nos seis casos restantes. A pontuac¸ão média na escala de Constant e Murley foi de 96
no  ﬁm do tratamento conservador com medicamentos anti-inﬂamatórios não esteroides e
ﬁsioterapia. Seis dos oito pacientes apresentaram boa recuperac¸ão da forc¸a muscular.
Conclusão: Na maioria dos casos a recuperac¸ão funcional foi boa, embora a forc¸a muscular
não  tenha sido completamente restaurada em alguns deles.
© 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier


































arsonage–Turner syndrome (PTS) is also named acute idio-
athic brachial neuritis, paralytic neuritis of the brachial
lexus, cryptogenic brachial neuropathy and scapular belt
yndrome. The ﬁrst records of this syndrome date from 1887,
escribed by Dreschfeld, and this was followed by many  other
eports: Feinberg1 (1897), Bramwell and Struthers2 (1903),
yburn-Mason3 (1941), Burnard4 (1942) and Spillane5 (1943).
owever, the clinical characteristics of this syndrome were
nly fully described in 1948, from a series of 136 cases reported
y Parsonage and Turner. These authors named it “scapular
elt syndrome”.6
This is a painful non-traumatic disorder that affects the
capular belt. Clinically, the patient presents a painful condi-
ion with localized upsurges in the shoulder that may last for
ome hours or up to two to three weeks, with spontaneous
mprovement. After the painful condition, muscle weakness
ppears, along with paralysis and atrophy of the innervated
usculature in the segment affected.7 Topographically, this
eurological lesion impairs the peripheral nerves or part of
he brachial plexus. In addition to the motor repercussions,
here may be sensory losses.
Diagnosing the disease may give rise to certain anxieties
oth for the attending physician and for the patient, since
ome conditions with similar characteristics may be con-
ounded with PTS and may need to be ruled out in making
he differential diagnosis. These conditions include rotator
uff tears, calcareous tendinitis, adhesive capsulitis, cervi-
al spondylopathy and neurological abnormalities such as
ompression of the peripheral nerve, acute poliomyelitis and
ateral amyotrophic sclerosis. However, the diagnosis becomes
robable when spontaneous improvement of the pain and
rogression of muscle weakness are observed.
The precise cause is unknown, but it has been attributed in
he literature to viral infections and autoimmune processes,8,9
uch as after immunization. There are also reports ofhereditary forms with speciﬁc mutations10 or even occur-
rences after strenuous physical exercise.11,12 Some viral
agents have been correlated with PTS, such as: smallpox,
fever, typhoid, inﬂuenza, coxsackievirus, parvovirus B19,
cytomegalovirus and human immunodeﬁciency virus, and
also Borrelia burgdorferi.8,13–16 There is strong evidence of an
association with viral infections, since there are reports in
the literature of epidemic outbreaks in isolated populations,
such as one that occurred in an indigenous population in the
southwestern United States, with eight cases of PTS.7
The incidence was found to be 1.64 cases per 100,000 inhab-
itants, in the population of Minnesota, United States, with
occurrences predominantly between the third and seventh
decades of life.17,18 Men are more  affected than women, with
a ratio of between 2:1 and 11.5:1.11 The prognosis is good in
most cases, given that PTS is self-limiting and has a low recur-
rence rate.11 The treatment is generally successful, with use of
analgesics and physiotherapy in order to maintain the range
of motion and strengthen muscles.
The objective of this study was to describe the clinical char-
acteristics of PTS and evaluate the results from conservative
treatment.
Materials  and  methods
Eight cases of PTS that were diagnosed between February 2010
and February 2012 were studied prospectively. The patients
were followed up for a minimum of one year (mean of 14
months). All the patients were asked to answer a clinical
questionnaire on their symptoms and underwent a physical
examination to assess function. At the end of the treatment,
all the patients were graded using the Constant and Murley
score.19After the clinical suspicion of PTS was raised, all of these
patients underwent electroneuromyography examination in
order to register the peripheral nerve that was affected and
conﬁrm the diagnosis. However, in some cases, with the aims
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Fig. 1 – Fifteen years and three months after the start of the
symptoms. Note the atrophy of the deltoid muscle in the
Fig. 2 – Patient with right-side winged scapula, resulting
The Constant and Murley scores obtained were between 94
and 100 points, with a mean of 96.37 points at the end of the
follow-up (Table 2). Six of the eight patients treated presented
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Fig. 3 – Magnetic resonance imaging of the shoulder: axialright shoulder.
of ruling out associated conditions and making a differential
diagnosis, radiography and magnetic resonance examinations
were used. The inclusion criteria were that the patents needed
to have a history of acute shoulder pain with paresis or
hypotrophy in the scapular belt. Patients with histories of
trauma, previous shoulder surgery, rotator cuff tears or adhe-
sive capsulitis were excluded. This study was approved by the
ethics committee.
Results
Eight patients were evaluated: three females and ﬁve males.
Their mean age was 29 years (range from 15 to 41). The right
side was affected in 70% of the cases and the dominant side
in 80% (Table 1).
All the patients studied reported during the history-taking
that they had experience a sudden condition of shoulder pain
that lasted for an average of one to ﬁve days. In two cases, the
pain lasted for 15 days. In three cases, there was spontaneous
remission of the painful condition without any use of non-
steroidal anti-inﬂammatory drugs (NSAIDs). In seven cases,
remission occurred through use of NSAIDs and analgesics that
were prescribed by doctors at the emergency service.
In the physical examination, which was performed on eight
patients, three cases presented intense atrophy in the area of
the deltoid muscle and one case showed hypoesthesia in the
sensory area of the axillary nerve (Fig. 1). Three cases showed
muscle hypotrophy in the supraspinous and infraspinous fos-
sae, with positive Jobe tests, which were used to evaluate the
functioning of the supraspinatus. The remaining two cases
showed winged scapulae, which were more  evident when the
patients used force to push against a wall (Fig. 2).
Electroneuromyography examinations were performed on
all the patients in order to conﬁrm the diagnosis. All
of these examinations demonstrated peripheral denerva-
tion (potential for prolonged action and latency). In one
case (patient 4), a magnetic resonance examination was
performed on the shoulder, which showed hypersignal
with T2 weighting and atrophy of the deltoid musculature
(Fig. 3).
A physiotherapeutic rehabilitation program was started
just after the diagnosis had been made. The protocol consistedfrom impairment of the long thoracic nerve.
of analgesic electrotherapy with TENS in association with
deep thermal therapy or cryotherapy during the painful phase,
kinesiotherapy to maintain and gain range of motion and,
when grades close to normality were reached, isometric or
resistance exercises were started for the entire scapular belt.
Functional electrical stimulation (FES) was also used with the
aim of increasing muscle tonus.
All the patients presented improvements in pain, strength
and muscle trophism (Fig. 4) over the course of the follow-up.slices with T2 weighting, (A) proximal and (B) distal.
Hypersignal and atrophy of the deltoid musculature (arrow)
can be seen, suggestive of denervation of the axillary nerve.
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Table 1 – Age, sex and limb affected among the patients with PTS.
Patient Age Sex Side affected Dominant side Duration of pain outbreak Peripheral nerve affecteda
1 37 Male Right Right 24 h Suprascapular
2 26 Male Right Right 48 h Long thoracic
3 41 Male Right Right 3 days Axillary
4 15 Female Right Right 15 days Axillary
5 23 Male Right Right 5 days Long thoracic
6 32 Male Left Right 24 h Suprascapular
7 30 Female Left Right 48 h Long thoracic
8 34 Female Right Right 15 days Suprascapular
Source: research data.
a Based on clinical examination and complementary electroneuromyogra
Fig. 4 – Patient with PTS in the right shoulder, affecting the
axillary nerve. (A) Atrophy in the area of the deltoid:
















Tfter three months of physiotherapeutic rehabilitation.
ull recovery of muscle strength. In the other two patients,
lthough muscle hypotrophy could still be seen, this did not
ave any repercussion on their daily and sports activities.
iscussion
he etiology of PTS is not well deﬁned, but it has been
ttributed to viral infections and autoimmune reactions. In
ome clinical reports, before the symptoms appeared, a period
f fever or infection of the upper airways or even an immuno-
ogical reaction after vaccination was described. No such
ssociation was determined in our study.
Males are more  frequently affected, in proportions that
ccording to the literature range from 2:1 to 11.5:1.11,18,20 There
s no preference regarding the laterality of the disorder, or
ny correlation with the dominant limb. However, one third of
he patients may be affected bilaterally and asymmetrically.21
urner described a case of bilateral impairment, six months
Table 2 – Results from Constant and Murley scores at the
end of the mean follow-up period of 14 months.






Source: research data.phy examination.
after the start of the symptoms. Around one third of the
patients develop PTS bilaterally.11 In our study, the proportions
relating to sex were 1.6 men  to one woman. The mean age was
29 years and there were no cases of bilaterality.
There is no consensus regarding the peripheral nerve most
frequently affected. According to Turner and Parsonage,11 the
long thoracic nerve is the one most affected. Magee and
DeJong20 and Tsairis et al.11 reported that the suprascapular
nerve was the one most frequently affected. According to Mul-
vey et al.,22 even the phrenic nerve can be affected in cases of
PTS. In our sample, it was seen that the long thoracic nerve
(n = 3) and suprascapular nerve (n = 3) were equally affected,
followed by the axillary nerve (n = 2).
The characteristic pattern of sudden pain with sponta-
neous improvement followed by weakness of the musculature
of the scapular belt is the key to diagnosing this syndrome. In
all of our patients, we  identiﬁed this pattern. The pain has
been described as severe and excruciating, and it may persist
for hours or even up to three or four weeks.23 In our patients,
the pain lasted on average for ﬁve days, with a minimum of
24 h and maximum of 15 days. The consequences of impair-
ment of the motor nerve ﬁbers, such as weakness and muscle
atrophy, were perceptible and constituted the patients’ main
complaint after the hyperalgesic phase. Regarding alterations
to sensitivity, such as analgesia and hypoesthesia, these were
minimal and often limited to a small area. These ﬁndings were
compatible with the classical descriptions and also with more
recent studies comprising case series with large numbers of
patients.12,24,25
Electroneuromyography examinations are important for
conﬁrming the diagnosis. Alterations on these examinations
are generally perceptible three weeks after the start of the
symptoms.26,27 These usually consist of acute denervation
and indicate situations of axonal degeneration, with poten-
tial positive ﬁbrillation spike waves. From magnetic resonance
examinations, the following ﬁndings in the musculature
affected have been described in the literature: intramuscular
edema and muscle atrophy that may or may not be associated
with fatty inﬁltration28,29 (Fig. 3). The increased signal with T2
weighting is due to muscle edema. According to Wessig et al.,30
there is an increase in capillary blood volume 48 h after muscle
denervation, which favors extravasation from intracapillary
sites to extracellular sites. These alterations, which have been
described in magnetic resonance examinations, were consis-
tent with what was observed in our patients (Fig. 3).
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The treatment for PTS can be divided into two phases. In
the ﬁrst phase (hyperalgesia), analgesics and rest for the limb
affected, with use of a sling, are prescribed. No corticosteroid
anti-inﬂammatory agents were used, since the etiological
identity of the syndrome could not be determined (i.e. viral or
autoimmune). Thus, we do not recommend use of this class
of drugs, although studies have shown that their use may
shorten the time taken for recovery of strength to start and
improve the pain during the acute phase.11,21 After the pain
has improved, the second phase can be started, which aims
to reestablish and maintain the range of motion, followed by
muscle strengthening. In 1960, Magee and DeJong20 reported
that full recovery might take as long as eight years. How-
ever, all the patients treated in our study over the 14-month
period presented improvements in trophism and strength in
the affected limb. Six of the eight patients declared that they
did not feel any difference in relation to strength and pain, in
comparison with the contralateral side.
Although Parsonage–Turner syndrome is not a common
condition in clinical practice, it is important that orthope-
dists should become familiar with it and include it in the
differential diagnosis when patients complain of pain and
weakness in the scapular belt. The diagnosis is clinical and
the electroneuromyography examination can be used to con-
ﬁrm it. Other examinations are only needed for the differential
diagnosis. The prognosis is good, with spontaneous resolu-
tion of the pain in around 80–90% of the cases.11,31 However,
strength is not always fully recovered and the condition may
present recurrence.11,12 Conservative treatment, comprising
use of analgesics and physiotherapeutic exercises, generally
brings satisfactory results, but there have been reports of sur-
gical treatment with tendon transfers, as late treatment for
loss of strength.
The present study has the advantage of providing a report
on a series of cases of a rare disease that needs to be
remembered as a differential diagnosis for a painful shoulder
condition, especially when associated with muscle weakness
and hypotrophy. The main disadvantage was the small num-
ber of patients in the sample. Nonetheless, our ﬁndings did not
diverge from the reports in the literature in other countries,
with large samples of patients.
Conclusion
Amyotrophic neuralgia is a pathological condition that is dif-
ﬁcult to diagnose in the acute phase. It most often presents as
an acute condition of intense pain in the scapular belt, which
is generally self-limited and in most cases evolves to func-
tional recovery. Careful clinical evaluation and early diagnosis
using electroneuromyography help toward adequate manage-
ment of the disease and bring reassurance for patients and
their doctors, along with information regarding the recovery.
Correct diagnosis also has the advantage of avoiding unnec-
essary examinations.Conﬂicts  of  interest
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 e  f  e  r  e  n  c  e  s
1. Feinberg J. Fall von Erb-Klumpke scher: lahmung nach
inﬂuenza. Centralbl. 1897;16:588–637.
2. Bramwell E, Struthers JW.  Paralysis of the serratus magnus
and lower part of the trapezius muscles. Rev Neurol Psychiatr.
1903;1:717–30.
3. Wyburn-Mason R. Brachial neuritis occurring in epidemic
form. Lancet. 1941;1:662–3.
4. Burnard ED, Fox TG. Multiple neuritis of shoulder girdle:
report of nine cases occurring in second New Zealand
expeditionary force. NZ Med J. 1942:41.
5. Spillane JD. Localised neuritis of the shoulder girdle: a report
of 46 cases in the MEF. Lancet. 1943;2:532–5.
6. Parsonage MJ, Turner JW. Neuralgic amyotrophy; the
shoulder-girdle syndrome. Lancet. 1948;1(6513):973–8.
7. Auge WK  2nd, Velazquez PA. Parsonage–Turner syndrome in
the  Native American Indian. J Shoulder Elbow Surg.
2000;9(2):99–103.
8. Pellas F, Olivares JP, Zandotti C, Delarque A. Neuralgic
amyotrophy after parvovirus B19 infection. Lancet.
1993;342(8869):503–4.
9. Suarez GA, Giannini C, Bosch EP, Barohn RJ, Wodak J, Ebeling
P, et al. Immune brachial plexus neuropathy: suggestive
evidence for an inﬂammatory-immune pathogenesis.
Neurology. 1996;46(2):559–61.
0. Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A,
Verpoorten N, Meuleman J, et al. Mutations in SEPT9 cause
hereditary neuralgic amyotrophy. Nat Genet.
2005;37(10):1044–6.
1. Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial
plexus neuropathy. Report on 99 patients. Arch Neurol.
1972;27(2):109–17.
2. Van Alfen N, van Engelen BGM. The clinical spectrum of
neuralgic amyotrophy in 246 cases. Brain. 2006;129 Pt
2:438–50.
3. Bardos V, Somodska V. Epidemiologic study of a brachial
plexus neuritis outbreak in northeast Czechoslovakia. World
Neurol. 1961;2:973–9.
4. Seror P, Harbach S. Parsonage–Turner syndrome after
cytomegalovirus infection. Presse Med. 1990;19(11):527–8.
5. Botella MS, Garcia M, Cuadrado JM, Martin R.
Parsonage–Turner syndrome in positive HIV patients. Rev
Neurol. 1997;25(137):143 [Letter].
6. Jiguet M, Troussier B, Phelip X. Parsonage and Turner
syndrome. Apropos of a case, with demonstration of Borrelia
burgdorferi infection. Rev Rhum Mal Osteoartic.
1991;58(5):409–11.
7. Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus
neuropathy in the population of Rochester, Minnesota,
1970–1981. Ann Neurol. 1985;18(3):320–3.
8. Turner JW,  Parsonage MJ. Neuralgic amyotrophy (paralytic
brachial neuritis); with special reference to prognosis. Lancet.
1957;273(6988):209–12.
9. Constant CR, Murley AH. A clinical method of functional
assessment of the shoulder. Clin Orthop Relat Res.
1987;(214):160–4.
0. Magee KR, Dejong RN. Paralytic brachial neuritis. Discussion
of  clinical features with review of 23 cases. JAMA.
1960;174:1258–62.
1. Van Alfen N. The neuralgic amyotrophy consultation. J
Neurol. 2007;254(6):695–704.
2. Mulvey DA, Aquilina RJ, Elliott MW, Moxham J, Green M.
Diaphragmatic dysfunction in neuralgic amyotrophy: an
electrophysiologic evaluation of 16 patients presenting with
dyspnea. Am Rev Respir Dis. 1993;147(1):
66–71.








3r e v b r a s o r t o p . 2
3. McCarty EC, Tsairis P, Warren RF. Brachial neuritis. Clin
Orthop Relat Res. 1999;(368):37–43.
4. Favero KJ, Hawkins RH, Jones MW. Neuralgic amyotrophy. J
Bone Jt Surg Br. 1987;69(2):195–8.
5. Misamore GW, Lehman DE. Parsonage–Turner syndrome
(acute brachial neuritis). J Bone Jt Surg Am. 1996;78(9):
1405–8.
6. Weikers NJ, Mattson RH. Acute paralytic brachial neuritis. A
clinical and electrodiagnostic study. Neurology.
1969;19(12):1153–8.
7. Rubin DI. Neuralgic amyotrophy: clinical features and
diagnostic evaluation. Neurologist. 2001;7(6):
350–6.
3;5 0(3):336–341 341
8. Scalf RE, Wenger DE, Frick MA, Mandrekar JN, Adkins MC. MRI
ﬁndings of 26 patients with Parsonage–Turner syndrome. AJR
Am J Roentgenol. 2007;189(1):W39–44.
9. Gaskin CM, Helms CA. Parsonage–Turner syndrome: MR
imaging ﬁndings and clinical information of 27 patients.
Radiology. 2006;240(2):501–7.
0. Wessig C, Koltzenburg M, Reiners K, Solymosi L, Bendszus M.
Muscle magnetic resonance imaging of denervation and
reinnervation: correlation with electrophysiology and
histology. Exp Neurol. 2004;185(2):254–61.
1. Tonali P, Uncini A, Di Pasqua PG. So-called neuralgic
amyotrophy: clinical features and long term follow-up. Ital J
Neurol Sci. 1983;4(4):431–7.
